Inhibition of kidney uptake of radiolabeled somatostatin analogs: amino acids or gelofusine?

Suppr

超能文献

作者信息

Rolleman Edgar J, de Jong Marion, Valkema Roelf, Kwekkeboom Dik, Kam Boen, Krenning Eric P

出版信息

J Nucl Med. 2006 Oct;47(10):1730-1; author reply 1731.

PMID:17015911

Abstract

摘要

相似文献

Inhibition of kidney uptake of radiolabeled somatostatin analogs: amino acids or gelofusine?

J Nucl Med. 2006 Oct;47(10):1730-1; author reply 1731.

Gelatin-based plasma expander effectively reduces renal uptake of 111In-octreotide in mice and rats.

J Nucl Med. 2006 Mar;47(3):528-33.

Renal uptake of radiolabeled octreotide in human subjects is efficiently inhibited by succinylated gelatin.

J Nucl Med. 2006 Mar;47(3):432-6.

Pre-clinical evaluation of 2,3-dimercaptosuccinic acid as a radiation nephrotoxicity protective agent during radiopeptide therapy of neuroendocrine malignancy.

Nucl Med Commun. 2007 Apr;28(4):261-6. doi: 10.1097/MNM.0b013e328014a11e.

Oral versus intravenous administration of lysine: equal effectiveness in reduction of renal uptake of [111In-DTPA]octreotide.

J Nucl Med. 2005 Dec;46(12):2057-60.

Therapy using labelled somatostatin analogues: comparison of the absorbed doses with 111In-DTPA-D-Phe1-octreotide and yttrium-labelled DOTA-D-Phe1-Tyr3-octreotide.

Nucl Med Commun. 2008 Mar;29(3):283-90. doi: 10.1097/MNM.0b013e3282f3d03e.

[The protection of mice against x-radiation using sodium succinate].

Radiobiologiia. 1990 Sep-Oct;30(5):704-6.

[The search for chemical compounds with potential radioprotective effects (review)].

Farmakol Toksikol. 1972 Nov-Dec;35(6):747-52.

MIBG and somatostatin receptor analogs in children: current concepts on diagnostic and therapeutic use.

J Nucl Med. 2005 Jan;46 Suppl 1:55S-61S.

[Protective effect of folcysteine against acute radiation sickness].

Arzneimittelforschung. 1967 Oct;17(10):1336-7.

引用本文的文献

Biodistribution-Driven Discovery Identifies a Glycosidase-Cleavable Linker to Reprogram Radiotheranostics.

bioRxiv. 2025 Sep 16:2025.09.11.675134. doi: 10.1101/2025.09.11.675134.

Amide-to-Triazole Switch in Somatostatin-14-Based Radioligands: Impact on Receptor Affinity and In Vivo Stability.

Pharmaceutics. 2024 Mar 13;16(3):392. doi: 10.3390/pharmaceutics16030392.

Towards the Magic Radioactive Bullet: Improving Targeted Radionuclide Therapy by Reducing the Renal Retention of Radioligands.

Pharmaceuticals (Basel). 2024 Feb 16;17(2):256. doi: 10.3390/ph17020256.

Bioorthogonal Chemistry Approach for the Theranostics of GRPR-Expressing Cancers.

Pharmaceutics. 2022 Nov 23;14(12):2569. doi: 10.3390/pharmaceutics14122569.

Application of Cleavable Linkers to Improve Therapeutic Index of Radioligand Therapies.

Molecules. 2022 Aug 4;27(15):4959. doi: 10.3390/molecules27154959.

Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues.

Eur J Nucl Med Mol Imaging. 2010 May;37(5):1018-31. doi: 10.1007/s00259-009-1282-y. Epub 2009 Nov 14.

Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumours.

Eur J Nucl Med Mol Imaging. 2009 Dec;36(12):1968-76. doi: 10.1007/s00259-009-1196-8.

Outcome of treating advanced neuroendocrine tumours with radiolabelled somatostatin analogues.

Clin Transl Oncol. 2009 Jan;11(1):48-53. doi: 10.1007/s12094-009-0310-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验